Nitric oxide promotes mitogen-induced DNA synthesis in human dermal fibroblasts through cGMP

Clinical and Experimental Pharmacology and Physiology

Volumn 31, Issue 1-2, 2004, Pages 46-49

  Dhaunsi, Gursev S ^a,b,c   Ozand, Pinar T ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^c KUWAIT UNIVERSITY   (Kuwait)

Author keywords

cGMP; Fibroblasts; Growth factor; Nitric oxide DNA synthesis; Skin; Wound healing

Indexed keywords

8 BROMO CYCLIC GMP; CYCLIC GMP; FIBROBLAST GROWTH FACTOR; GROWTH FACTOR; MITOGENIC AGENT; NITRIC OXIDE; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM; PLATELET DERIVED GROWTH FACTOR; THYMIDINE;

ARTICLE; CONTROLLED STUDY; DNA SYNTHESIS; DRUG POTENTIATION; DRUG PROTEIN BINDING; HUMAN; HUMAN CELL; HUMAN TISSUE; SKIN BIOPSY; SKIN FIBROBLAST; TISSUE CULTURE CELL; WOUND HEALING;

CELLS, CULTURED; CYCLIC GMP; DNA; FIBROBLASTS; GROWTH SUBSTANCES; HUMANS; MITOGENS; NITRIC OXIDE; NITRIC OXIDE DONORS; NITROPRUSSIDE; PLATELET-DERIVED GROWTH FACTOR; SKIN; THYMIDINE; WOUND HEALING;

EID: 1242314840     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2004.03948.x     Document Type: Article

References (24)

1. 2+ influx. Circ. Res. 1999; 84: 210-19.
2. Garthwaite J, Boulton CL. Nitric oxide signaling in the central nervous sytem. Annu. Rev. Physiol. 1995; 57: 683-706.
3. Billiar TR. Nitric oxide. Novel biology with clinical relevance. Ann. Surg. 1995; 221: 339-49.
4. Nathan C, Xie QW. Regulation of biosynthesis of nitric oxide. J. Biol. Chem. 1991; 269: 13 725-8.
5. Stuehr DJ. Mammalian nitric oxide synthases. Biochem. Biophys. Acta 1999; 1411: 217-30.
6. Bruch-Gerharz D, Ruzicka T, Kolb-Bachofen V. Nitric oxide in human skin: Current status and future prospects. J. Invest. Dermatol. 1998; 110: 1-7.
7. Wang R, Ghahary A, Shen YJ, Scott PG, Tredget EE. Human dermal fibroblasts produce nitric oxide and express both constitutive and inducible nitric oxide synthase isoforms. J. Invest. Dermatol. 1996; 106: 419-27.
8. Akcay MN, Ozcan O, Gundogdu C et al. Effect of nitric oxide synthase inhibitor on experimentally induced burn wounds. J. Trauma Injury Inf. Crit. Care 2000; 49: 327-30.
9. Witte MB, Thornton FJ, Efron DT, Barbul A. Enhancement of fibroblast collagen synthesis by nitric oxide. Nitric Oxide 2000; 4: 572-82.
10. Wetzler C, Kampfer H, Pfeilschifter J, Frank S. Keratinocyte-derived chemotactic cytokines: Expressional modulation by nitric oxide in vitro and during cutaneous wound repair in vivo. Biochem. Biophys. Res. Commun. 2000; 274: 689-96.
11. Frank S, Stallmeyer B, Kamfer H, Kolb N, Pfeilschifter J. Nitric oxide triggeres enhanced induction of vascular endothelial growth factor expression in cultured keratinocytes (HaCaT) and during cutaneous wound repair. FASEB J. 1999; 13: 2002-14.
12. Pirtskhalishvili G, Nelson JB. Endothelium-derived factors as paracrine mediators of prostate cancer progression. Prostate 2000; 44: 77-87.
13. Harris SR, Schoeffner DJ, Yoshiji H, Thorgeirsson UP. Tumor growth enhancing effects of vascular endothelial growth factor are associated with increased nitric oxide synthase activity and inhibition of apoptosis in human breast carcinoma xenografts. Cancer Lett. 2002; 179: 95-101.
14. Hassid A, Arabshahi H, Bourcier T, Dhaunsi G, Matthews C. Nitric oxide selectively amplifies FGF-2-induced mitogenesis in primary rat aortic smooth muscle cells. Am. J. Physiol. 1994; 267: H1040-8.
15. Dhaunsi GS, Hassid A. Atrial and C-type natriuretic peptides amplify growth factor activity in primary aortic smooth muscle cells. Cardiovasc. Res. 1996; 31: 37-47.
16. Lee RH, Efron D, Tantry U, Barbul A. Nitric oxide in the healing wound: A time-course study. J. Surg. Res. 2001; 101: 104-8.
17. Phoa N, Epe B. Influence of nitric oxide on the generation and repair of oxidative DNA damage in mammalian cells. Carcinogenesis 2002; 23: 469-75.
18. Cheng ML, Ho HY, Liang CM et al. Cellular glucose-6-phosphate dehydrogenase (G6PD) status modulates effects of nitric oxide on human foreskin fibroblast. FEBS Lett. 2000; 475: 257-62.
19. Wang J, Monta I, Onodera M, Murota SI. Induction of KDR expression in bovine arterial endothelial cells by thrombin: Involvement of nitric oxide. J. Cell. Physiol. 2002; 190: 238-50.
20. Gross SS, Wolin MS. Nitric oxide: Pathophysiological mechanisms. Annu. Rev. Physiol. 1995; 57: 737-69.
21. Dhaunsi GS, Matthews CY, Kaur K, Hassid A. NO increases protein tyrosine phosphatase activity in smooth muscle cells: Relationship to antimitogenesis. Am. J. Physiol. 1997; 272: H1342-9.
22. Morgan RO, Newby AC. Nitroprusside differentially inhibits ADP-stimulated calcium influx and mobilization in human platelets. Biochem. J. 1989; 258: 447-54.
23. Lincoln TM, Komalavilas P, Boerth NJ, MacMillan-Crow LA, Cornwell TL. cGMP signaling through cAMP-and cGMP-dependent protein kinases. Adv. Pharmacol. 1995; 34: 305-22.
24. Arnold WP, Mittal CK, Murad F. Nitric oxide activates guanylate cyclase and increases guanosine 3′,5′-cyclic monophosphate levels in various tissue preparations. Proc. Natl Acad. Sci. USA 1977; 74: 3203-7.